News
news

News Releases

DateSubject
Dec 28, 2009 /C O R R E C T I O N from Source -- Medicago Inc./
Dec 24, 2009 Medicago grants stock options
Dec 21, 2009 Medicago reports positive Phase I results for its avian flu pandemic vaccine
Dec 14, 2009 Medicago announces conversion of Medicago's subscription receipts into units
Nov 27, 2009 Medicago announces 2009 third quarter financial results
Nov 27, 2009 Medicago announces completion of bought deal financing
Nov 19, 2009 Medicago announces filing of final short form prospectus
Nov 18, 2009 Medicago to present at the Influenza Congress USA 2009
Nov 12, 2009 Medicago announces filing of preliminary short form prospectus
Nov 06, 2009 Medicago announces $10,080,000 bought deal equity financing
Nov 04, 2009 Medicago to present at the U.S. Department of Health and Human Services' Global Health Security Initiative Workshop
Oct 19, 2009 Former Premier of Quebec Pierre Marc Johnson joins Medicago's Board of Directors
Oct 08, 2009 Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy
Oct 01, 2009 Medicago begins human clinical testing with its avian flu pandemic vaccine
Sep 02, 2009 Medicago to collaborate with Tabuk for commercial development of influenza vaccines in Saudi Arabia and other territories
Aug 26, 2009 Medicago announces 2009 second quarter financial results
Aug 25, 2009 Medicago receives regulatory approval to begin human clinical testing with its avian flu pandemic vaccine
Aug 20, 2009 Medicago signs MOU with Ajanta Pharma for commercial development of influenza vaccines in India and other territories
Jul 30, 2009 Medicago's H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose
Jul 21, 2009 Medicago and Genopole(R) sign agreement for influenza vaccine production in France
Jul 16, 2009 Medicago's Avian flu pandemic vaccine achieves 100% protection in a lethal challenge study in ferrets
Jun 30, 2009 Medicago's vaccine candidate against novel influenza A (H1N1) virus immunogenic in mice
Jun 08, 2009 Medicago announces presentation at the World Vaccine Congress Asia 2009
Jun 08, 2009 Medicago awarded $1.77 million in funding from Quebec's Consortium for Drug Discovery
May 27, 2009 Medicago announces 2009 First Quarter Financial Results
May 15, 2009 Medicago receives 2009 Genesis Innovation Award
May 13, 2009 Medicago named Early Stage Company of the Year by BIOTECanada
May 12, 2009 Medicago successfully expresses VLP antigen for a H1N1 strain
Apr 28, 2009 Medicago initiates work on swine flu strain
Mar 25, 2009 Medicago announces 2008 Fourth Quarter and Year-End Financial Results
Mar 17, 2009 Medicago forms new Scientific Advisor Council with highly regarded experts
Jan 27, 2009 Medicago announces poster presentation at the IDSA Seasonal and Pandemic Influenza 2009 meeting
Jan 15, 2009 Medicago appoints new member to Board of Directors and grants stock options